Latest Breaking News On - Beacon select - Page 1 : comparemela.com

Smart Beacon Market is estimated to be US$ 31,746 0 Million by 2032 with a CAGR of 31 5% over the forecast period (2022-2032)

Smart Beacon Market is estimated to be US$ 31,746 0 Million by 2032 with a CAGR of 31 5% over the forecast period (2022-2032)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesAsia pacificHewlett packard enterprise companySwirl networksZebra technologies corpOthers by connectivity type bluetooth low energyCisco systems incGlobal companyBluetooth low energySensor co ltdBerkeley lights incEstimote incRadious networks incLeantegra incMarket insightsSmart beacon market

PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update

Strategic Alternatives Process Continuing; Board Focused on Maximizing Stockholder Value EMERYVILLE, Calif., Aug. 14, 2023 /PRNewswire/ PhenomeX, Inc. , a life sciences tools company, today. -Today at 04:06 pm- MarketScreener

United statesYan zhangPrnewswire phenomex incWhile the companyCell line development workflowPhenomex incExchange commissionStrategic alternatives process continuingBoard focusedMaximizing stockholderBeacon questBeacon selectSiddhartha kadiaLine development workflowSecond amended loan agreementEast west bank

PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the second quarter ended June 30, 2023..

United statesYan zhangPrnewswire phenomex incCell line development workflowWhile the companyExchange commissionPhenomex incStrategic alternatives process continuingBoard focusedMaximizing stockholderBeacon questBeacon selectSiddhartha kadiaLine development workflowSecond amended loan agreementEast west bank

PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023

/PRNewswire/ PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation in the Antibody Engineering & Therapeutics.

Noord hollandFrancois romagneAix marseille universityPhenomex incPostillion hotel amsterdamBeacon single cell technologyPrnewswire phenomex incBeacon selectAntibody engineeringPostillion hotelAix marseilleAntibody discoveryDifficult targetsBeacon single cell

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

Affordable two-chip Beacon Select system to broaden customer access to innovative high throughput, function-first antibody discovery capabilities.

Hynes convention centerUnited statesCdmos crosPhenomex incOptob discoveryBeacon selectAntibody discovery workflowProtein engineeringCell therapy summitAntibody discoveryCell biology